Rudich Steven M, Kaplan Bruce, Magee John C, Arenas Juan D, Punch Jeffrey D, Kayler Liise K, Merion Robert M, Meier-Kriesche Herwig-Ulf
Division of Transplant Surgery, University of Michigan Medical Center, Ann Arbor, MI, USA.
Transplantation. 2002 Dec 27;74(12):1715-20. doi: 10.1097/00007890-200212270-00013.
As more expanded-criteria organ donors are used to bridge the widening gap between organ supply and demand, non-heart-beating (NHB) donors will become increasingly important. The purpose of this study was to analyze renal transplant outcomes using this source of cadaveric (CAD) organs and compare the results with heart-beating organ sources.
Data from 98,698 adult CAD renal transplant recipients and 34,531 living donor renal transplant recipients registered in the U. S. Renal Data System database between January 1993 and June 2000 were analyzed. Kaplan-Meier survival curves were used to compare graft and patient survival rates between NHB, CAD, and living donor transplant recipients. Cox proportional hazards models were used to identify risk factors for NHB donor recipients, while adjusting for potential confounding variables.
Recipients of NHB donor organs experienced nearly twice the incidence of delayed graft function (DGF) compared with heart-beating donors (42.4% vs. 23.3%, respectively). NHB donor transplants experienced comparable allograft survival when compared with CAD transplants at 6 years (73.2% vs. 72.5%, respectively; P=NS); patient survival was greater at 6 years for NHB compared with CAD renal transplant recipients (80.9% vs. 77.8%, respectively; P=NS). Significant factors for allograft loss for NHB donor organ recipients included the following: organ used for repeat transplants; DGF; donor age older than 35 years; and head trauma as a cause of initial injury (relative risk 2.74, 1.90, 1.78, and 1.41, respectively).
Although exhibiting elevated DGF rates, allograft and patient survival rates of transplants from NHB donor sources are equivalent to those from conventional CAD sources. Donor age, recipient transplant number, female recipient, mechanism of injury, and DGF were the most pertinent variables leading to poor outcomes.
随着越来越多的扩大标准器官捐献者被用于弥合器官供需之间不断扩大的差距,非心脏跳动(NHB)捐献者将变得越来越重要。本研究的目的是分析使用这种尸体(CAD)器官来源进行肾移植的结果,并将结果与心脏跳动器官来源进行比较。
分析了1993年1月至2000年6月期间在美国肾脏数据系统数据库中登记的98,698例成年CAD肾移植受者和34,531例活体供肾移植受者的数据。采用Kaplan-Meier生存曲线比较NHB、CAD和活体供体移植受者之间的移植物和患者生存率。使用Cox比例风险模型确定NHB供体受者的风险因素,同时调整潜在的混杂变量。
与心脏跳动供体相比,NHB供体器官的受者发生移植肾功能延迟(DGF)的发生率几乎高出一倍(分别为42.4%和23.3%)。与CAD移植相比,NHB供体移植在6年时的同种异体移植物存活率相当(分别为73.2%和72.5%;P=无显著性差异);与CAD肾移植受者相比,NHB肾移植受者在6年时的患者生存率更高(分别为80.9%和77.8%;P=无显著性差异)。NHB供体器官受者同种异体移植物丢失的显著因素包括:用于再次移植的器官;DGF;供体年龄大于35岁;以及头部外伤作为初始损伤的原因(相对风险分别为2.74、1.90、1.78和1.41)。
尽管NHB供体来源的移植DGF率升高,但其同种异体移植物和患者生存率与传统CAD来源相当。供体年龄、受者移植次数、女性受者、损伤机制和DGF是导致不良结果的最相关变量。